<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <title>Schizophrenia severity reduced somewhat by daily 2,000 IU of Vitamin D â€“ RCT</title>
    <link rel="stylesheet" href="/css/main.css?v=1742566339">
    <link rel="stylesheet" href="/css/pagination.css?v=1742566339">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <script src="https://unpkg.com/lunr/lunr.js"></script>
    <script src="/js/search.js?v=1742566339"></script>
</head>
<body>
    <div class="container">
        <div class="sidebar">
            <h2>Search</h2>
            <div class="search-container">
                <input type="text" id="search-input" placeholder="Loading search index..." disabled>
                <div id="search-status" class="search-status">Loading search index...</div>
                <div id="suggestions" class="search-suggestions"></div>
            </div>
            <ul id="search-results"></ul>
            
            <h2>Categories</h2>
            <ul data-spa-nav>
                
                <li><a href="/categories/about-d---introduction/">About D - Introduction (3)</a></li>
                
                <li><a href="/categories/about-d---more-info./">About D - More Info. (3)</a></li>
                
                <li><a href="/categories/adhd/">ADHD (5)</a></li>
                
                <li><a href="/categories/admin-only/">Admin Only (5)</a></li>
                
                <li><a href="/categories/ai/">AI (31)</a></li>
                
                <li><a href="/categories/antibiotics-probiotics/">Antibiotics, Probiotics (4)</a></li>
                
                <li><a href="/categories/associations/">Associations (1)</a></li>
                
                <li><a href="/categories/autism/">Autism (10)</a></li>
                
                <li><a href="/categories/autoimmune/">Autoimmune (9)</a></li>
                
                <li><a href="/categories/back-pain/">Back Pain (3)</a></li>
                
                <li><a href="/categories/better-than-daily/">Better Than Daily (6)</a></li>
                
                <li><a href="/categories/bipolar/">Bipolar (1)</a></li>
                
                <li><a href="/categories/bone---health/">Bone - Health (12)</a></li>
                
                <li><a href="/categories/books-videos-on-vitamin-d/">Books, Videos on Vitamin D (28)</a></li>
                
                <li><a href="/categories/breathing/">Breathing (16)</a></li>
                
                <li><a href="/categories/calcidiol/">Calcidiol (2)</a></li>
                
                <li><a href="/categories/cancer/">Cancer (30)</a></li>
                
                <li><a href="/categories/cancer---after-diagnosis/">Cancer - After Diagnosis (12)</a></li>
                
                <li><a href="/categories/cancer---bladder/">Cancer - Bladder (2)</a></li>
                
                <li><a href="/categories/cancer---breast/">Cancer - Breast (13)</a></li>
                
                <li><a href="/categories/cancer---colon/">Cancer - Colon (8)</a></li>
                
                <li><a href="/categories/cancer---leukemia/">Cancer - Leukemia (1)</a></li>
                
                <li><a href="/categories/cancer---liver/">Cancer - Liver (1)</a></li>
                
                <li><a href="/categories/cancer---lung/">Cancer - Lung (1)</a></li>
                
                <li><a href="/categories/cancer---lymphoma/">Cancer - Lymphoma (1)</a></li>
                
                <li><a href="/categories/cancer---other/">Cancer - Other (7)</a></li>
                
                <li><a href="/categories/cancer---ovarian/">Cancer - Ovarian (2)</a></li>
                
                <li><a href="/categories/cancer---pancreatic/">Cancer - Pancreatic (1)</a></li>
                
                <li><a href="/categories/cancer---prostate/">Cancer - Prostate (4)</a></li>
                
                <li><a href="/categories/cancer---skin/">Cancer - Skin (5)</a></li>
                
                <li><a href="/categories/cardiovascular/">Cardiovascular (35)</a></li>
                
                <li><a href="/categories/category/">Category (1)</a></li>
                
                <li><a href="/categories/cholesterol/">Cholesterol (1)</a></li>
                
                <li><a href="/categories/cognitive/">Cognitive (34)</a></li>
                
                <li><a href="/categories/conference/">Conference (1)</a></li>
                
                <li><a href="/categories/consensus/">Consensus (3)</a></li>
                
                <li><a href="/categories/cost-savings-with-vitamin-d/">Cost Savings With Vitamin D (10)</a></li>
                
                <li><a href="/categories/curcumin/">Curcumin (1)</a></li>
                
                <li><a href="/categories/cyp27b1/">CYP27B1 (6)</a></li>
                
                <li><a href="/categories/cystic-fibrosis/">Cystic Fibrosis (2)</a></li>
                
                <li><a href="/categories/deficiency-of-vitamin-d/">Deficiency of Vitamin D (28)</a></li>
                
                <li><a href="/categories/dental/">Dental (18)</a></li>
                
                <li><a href="/categories/depression/">Depression (17)</a></li>
                
                <li><a href="/categories/diabetes/">Diabetes (23)</a></li>
                
                <li><a href="/categories/epilepsy/">Epilepsy (1)</a></li>
                
                <li><a href="/categories/evidence-for-d/">Evidence for D (7)</a></li>
                
                <li><a href="/categories/falls-and-fractures/">Falls and Fractures (21)</a></li>
                
                <li><a href="/categories/fertility-and-sperm/">Fertility and Sperm (10)</a></li>
                
                <li><a href="/categories/food-sources-for-vitamin-d/">Food Sources for Vitamin D (2)</a></li>
                
                <li><a href="/categories/forms-of-vitamin-d/">Forms of Vitamin D (8)</a></li>
                
                <li><a href="/categories/fortification-with-vitamin-d/">Fortification With Vitamin D (8)</a></li>
                
                <li><a href="/categories/genetics/">Genetics (19)</a></li>
                
                <li><a href="/categories/greger/">Greger (4)</a></li>
                
                <li><a href="/categories/gut/">Gut (13)</a></li>
                
                <li><a href="/categories/headache/">Headache (4)</a></li>
                
                <li><a href="/categories/health/">Health (14)</a></li>
                
                <li><a href="/categories/high-risk/">High Risk (3)</a></li>
                
                <li><a href="/categories/high-dose/">High-Dose (9)</a></li>
                
                <li><a href="/categories/how-much-vitamin-d/">How Much Vitamin D (4)</a></li>
                
                <li><a href="/categories/how-when-to-take-vit.-d/">How, When to Take Vit. D (4)</a></li>
                
                <li><a href="/categories/hypertension/">Hypertension (6)</a></li>
                
                <li><a href="/categories/immunity/">Immunity (13)</a></li>
                
                <li><a href="/categories/increased-use-of-d/">Increased Use of D (2)</a></li>
                
                <li><a href="/categories/infant-child/">Infant-Child (64)</a></li>
                
                <li><a href="/categories/inflammation/">Inflammation (12)</a></li>
                
                <li><a href="/categories/interactions-with-vitamin-d/">Interactions With Vitamin D (11)</a></li>
                
                <li><a href="/categories/intervention/">Intervention (39)</a></li>
                
                <li><a href="/categories/intervention---non-daily/">Intervention - Non Daily (21)</a></li>
                
                <li><a href="/categories/iodine/">Iodine (1)</a></li>
                
                <li><a href="/categories/kidney/">Kidney (7)</a></li>
                
                <li><a href="/categories/liver/">Liver (3)</a></li>
                
                <li><a href="/categories/loading-dose-for-vitamin-d/">Loading Dose for Vitamin D (9)</a></li>
                
                <li><a href="/categories/lupus/">Lupus (3)</a></li>
                
                <li><a href="/categories/meta-analysis-of-vitamin-d/">Meta-Analysis of Vitamin D (52)</a></li>
                
                <li><a href="/categories/metabolic-syndrome/">Metabolic Syndrome (10)</a></li>
                
                <li><a href="/categories/microbiome/">Microbiome (6)</a></li>
                
                <li><a href="/categories/middle-east/">Middle East (2)</a></li>
                
                <li><a href="/categories/mortality-and-d/">Mortality and D (23)</a></li>
                
                <li><a href="/categories/multiple-sclerosis/">Multiple Sclerosis (21)</a></li>
                
                <li><a href="/categories/noontime-sun-and-d/">Noontime Sun and D (11)</a></li>
                
                <li><a href="/categories/obesity/">Obesity (29)</a></li>
                
                <li><a href="/categories/off-topic/">Off Topic (5)</a></li>
                
                <li><a href="/categories/optimum/">Optimum (4)</a></li>
                
                <li><a href="/categories/orient/">Orient (4)</a></li>
                
                <li><a href="/categories/osteoarthritis/">Osteoarthritis (1)</a></li>
                
                <li><a href="/categories/osteoporosis/">Osteoporosis (13)</a></li>
                
                <li><a href="/categories/overview-for-doctors/">Overview for Doctors (1)</a></li>
                
                <li><a href="/categories/pain---chronic/">Pain - Chronic (8)</a></li>
                
                <li><a href="/categories/parkinson/">Parkinson (14)</a></li>
                
                <li><a href="/categories/patent/">Patent (1)</a></li>
                
                <li><a href="/categories/predict-vitamin-d/">Predict Vitamin D (3)</a></li>
                
                <li><a href="/categories/pregnancy/">Pregnancy (48)</a></li>
                
                <li><a href="/categories/psoriasis/">Psoriasis (5)</a></li>
                
                <li><a href="/categories/quality-of-life/">Quality of Life (3)</a></li>
                
                <li><a href="/categories/resveratrol/">Resveratrol (2)</a></li>
                
                <li><a href="/categories/rheumatoid-arthritis/">Rheumatoid Arthritis (6)</a></li>
                
                <li><a href="/categories/rickets/">Rickets (1)</a></li>
                
                <li><a href="/categories/season-of-birth/">Season of Birth (1)</a></li>
                
                <li><a href="/categories/seniors/">Seniors (27)</a></li>
                
                <li><a href="/categories/shut-in/">Shut-In (2)</a></li>
                
                <li><a href="/categories/skin/">Skin (8)</a></li>
                
                <li><a href="/categories/skin---dark/">Skin - Dark (9)</a></li>
                
                <li><a href="/categories/sleep/">Sleep (7)</a></li>
                
                <li><a href="/categories/sports-and-vitamin-d/">Sports and Vitamin D (10)</a></li>
                
                <li><a href="/categories/stroke/">Stroke (12)</a></li>
                
                <li><a href="/categories/supplement/">Supplement (4)</a></li>
                
                <li><a href="/categories/technical-d/">Technical D (1)</a></li>
                
                <li><a href="/categories/tests-for-vitamin-d/">Tests for Vitamin D (3)</a></li>
                
                <li><a href="/categories/thyroid-and-parathyroid/">Thyroid and Parathyroid (1)</a></li>
                
                <li><a href="/categories/top-news/">Top News (7)</a></li>
                
                <li><a href="/categories/toxicity-of-vitamin-d/">Toxicity of Vitamin D (1)</a></li>
                
                <li><a href="/categories/trauma-and-surgery/">Trauma and Surgery (15)</a></li>
                
                <li><a href="/categories/tuberculosis/">Tuberculosis (3)</a></li>
                
                <li><a href="/categories/uv-and-vitamin-d/">UV and Vitamin D (14)</a></li>
                
                <li><a href="/categories/veterinary-and-vitamin-d/">Veterinary and Vitamin D (4)</a></li>
                
                <li><a href="/categories/virus/">Virus (160)</a></li>
                
                <li><a href="/categories/vision/">Vision (14)</a></li>
                
                <li><a href="/categories/vit-d-binding-protein/">Vit D Binding Protein (8)</a></li>
                
                <li><a href="/categories/vitamin-b12/">Vitamin B12 (5)</a></li>
                
                <li><a href="/categories/vitamin-c/">Vitamin C (4)</a></li>
                
                <li><a href="/categories/vitamin-d-and-boron/">Vitamin D and Boron (6)</a></li>
                
                <li><a href="/categories/vitamin-d-and-calcium/">Vitamin D and Calcium (6)</a></li>
                
                <li><a href="/categories/vitamin-d-and-iron/">Vitamin D and Iron (3)</a></li>
                
                <li><a href="/categories/vitamin-d-and-magnesium/">Vitamin D and Magnesium (22)</a></li>
                
                <li><a href="/categories/vitamin-d-and-omega-3/">Vitamin D and Omega-3 (18)</a></li>
                
                <li><a href="/categories/vitamin-d-and-vitamin-a/">Vitamin D and Vitamin A (1)</a></li>
                
                <li><a href="/categories/vitamin-d-and-vitamin-k/">Vitamin D and Vitamin K (8)</a></li>
                
                <li><a href="/categories/vitamin-d-far-from-equator/">Vitamin D Far From Equator (4)</a></li>
                
                <li><a href="/categories/vitamin-d-in-australia-and-new-zealand/">Vitamin D in Australia and New Zealand (2)</a></li>
                
                <li><a href="/categories/vitamin-d-in-canada/">Vitamin D in Canada (2)</a></li>
                
                <li><a href="/categories/vitamin-d-in-europe/">Vitamin D in Europe (4)</a></li>
                
                <li><a href="/categories/vitamin-d-receptor/">Vitamin D Receptor (39)</a></li>
                
                <li><a href="/categories/vitamin-d3-instead-of-d2/">Vitamin D3 Instead of D2 (1)</a></li>
                
                <li><a href="/categories/women/">Women (13)</a></li>
                
                <li><a href="/categories/youth/">Youth (8)</a></li>
                
                <li><a href="/categories/zinc/">Zinc (6)</a></li>
                
            </ul>
        </div>
        <div class="content" role="main">
            
    <article>
        <h1>Schizophrenia severity reduced somewhat by daily 2,000 IU of Vitamin D â€“ RCT</h1>
        <time>August 7, 2023</time>
        <!-- {maketoc Title=""} -->
<hr>
<h4 id="a-randomized-controlled-trial-of-vitamin-d-supplementation-in-iranian-patients-with-schizophrenia-effects-on-serum-levels-of-glycogen-synthase-kinase-3Î²-and-symptom-severity">A Randomized Controlled Trial of Vitamin D Supplementation in Iranian Patients With Schizophrenia: Effects on Serum Levels of Glycogen Synthase kinase-3Î² and Symptom Severity</h4>
<p>Int J Psychiatry Med. 2023 Aug 6; <a href="https://doi.org/10.1177/00912174231193303">doi: 10.1177/00912174231193303</a> Â  behind a $41 paywall</p>
<p>Parinaz Kalejahi 1, Sorayya Kheirouri 1, Seyed Gholamreza Noorazar 2</p>
<p>Background: Growing evidence has shown that hypovitaminosis D is a risk factor for developing schizophrenia and comorbid conditions. Therefore, this study aimed to examine the effect of vitamin D supplementation on serum levels of vitamin D, metabolic factors related to insulin resistance (IR) and the severity of the disorder in patients with schizophrenia.</p>
<p>Methods: Forty-eight chronic male patients with schizophrenia with vitamin D deficiency (â‰¤20 ng/mL= (â‰¤50 nmol/l) were selected and randomly assigned to vitamin D treatment and placebo groups. Subjects were supplemented for 8 weeks with vitamin D (2000 IU/day) and placebo, respectively.</p>
<p>Results: Within-group comparison revealed that the vitamin D group had a significant reduction in waist circumference, Positive and Negative Syndrome Scale - total score (PANSS-TS) and, glycogen synthase kinase 3 beta (GSK-3Î²) levels (P = .022, p = &lt;.001 and P = .013 respectively). On the other hand, the placebo group showed a significant increase in the level of fasting serum insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) (P = .003 and P = .003). The between-group comparison showed a significant difference in terms of PANSS-TS, GSK-3Î², Fasting serum insulin (FSI) and HOMA-IR (P = .022, P = .048, P = .013 and P = .014 respectively).</p>
<p>Conclusions: Among vitamin D deficient patients with schizophrenia, vitamin D supplementation may affect GSK-3 Î², an important biomarker in schizophrenia and insulin resistance. In addition, vitamin D supplementation in such patients may reduce symptom severity.</p>
<hr>
<h4 id="vitamindwiki---a-hrefpostsoverview-schizophrenia-and-vitamin-d-stylecolor-red-text-decoration-underline-titlethis-postcategory-does-not-exist-yet-overview-schizophrenia-and-vitamin-doverview-schizophrenia-and-vitamin-da-contains">VitaminDWiki - <a href="/posts/overview-schizophrenia-and-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview Schizophrenia and Vitamin D">Overview Schizophrenia and Vitamin D</a> contains</h4>
<hr>
<h4 id="vitamindwiki---a-hrefpostsevery-schizophrenia-measure-was-improved-when-vitamin-d-levels-were-normalized-stylecolor-red-text-decoration-underline-titlethis-postcategory-does-not-exist-yet-every-schizophrenia-measure-was-improved-when-vitamin-d-levels-were-normalized--june-2021every-schizophrenia-measure-was-improved-when-vitamin-d-levels-were-normalized--june-2021a">VitaminDWiki - <a href="/posts/every-schizophrenia-measure-was-improved-when-vitamin-d-levels-were-normalized" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021">Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021</a></h4>
<p><strong>The goal: everyone &gt; 30 ng</strong></p>
<p><strong>Those with the lowest vitamin D levels were given 50,000 IU weekly for 8 weeks</strong></p>
<pre style="background-color: #e0e0e0;">
<code class="language-text">
Markdown:
--------

&lt;!-- {maketoc Title=&quot;&quot;} --&gt;

---

#### A Randomized Controlled Trial of Vitamin D Supplementation in Iranian Patients With Schizophrenia: Effects on Serum Levels of Glycogen Synthase kinase-3Î² and Symptom Severity

Int J Psychiatry Med. 2023 Aug 6; [doi: 10.1177/00912174231193303](https://doi.org/10.1177/00912174231193303) &amp;nbsp; behind a $41 paywall

Parinaz Kalejahi 1, Sorayya Kheirouri 1, Seyed Gholamreza Noorazar 2

Background: Growing evidence has shown that hypovitaminosis D is a risk factor for developing schizophrenia and comorbid conditions. Therefore, this study aimed to examine the effect of vitamin D supplementation on serum levels of vitamin D, metabolic factors related to insulin resistance (IR) and the severity of the disorder in patients with schizophrenia.

Methods: Forty-eight chronic male patients with schizophrenia with vitamin D deficiency (â‰¤20 ng/mL= (â‰¤50 nmol/l) were selected and randomly assigned to vitamin D treatment and placebo groups. Subjects were supplemented for 8 weeks with vitamin D (2000 IU/day) and placebo, respectively.

Results: Within-group comparison revealed that the vitamin D group had a significant reduction in waist circumference, Positive and Negative Syndrome Scale - total score (PANSS-TS) and, glycogen synthase kinase 3 beta (GSK-3Î²) levels (P = .022, p = &lt;.001 and P = .013 respectively). On the other hand, the placebo group showed a significant increase in the level of fasting serum insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) (P = .003 and P = .003). The between-group comparison showed a significant difference in terms of PANSS-TS, GSK-3Î², Fasting serum insulin (FSI) and HOMA-IR (P = .022, P = .048, P = .013 and P = .014 respectively).

Conclusions: Among vitamin D deficient patients with schizophrenia, vitamin D supplementation may affect GSK-3 Î², an important biomarker in schizophrenia and insulin resistance. In addition, vitamin D supplementation in such patients may reduce symptom severity.

---

#### VitaminDWiki - &lt;a href=&quot;/posts/overview-schizophrenia-and-vitamin-d&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Overview Schizophrenia and Vitamin D&quot;&gt;Overview Schizophrenia and Vitamin D&lt;/a&gt; contains

---

#### VitaminDWiki - &lt;a href=&quot;/posts/every-schizophrenia-measure-was-improved-when-vitamin-d-levels-were-normalized&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021&quot;&gt;Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021&lt;/a&gt;

 **The goal: everyone &gt; 30 ng** 

 **Those with the lowest vitamin D levels were given 50,000 IU weekly for 8 weeks** 



AST Structure:
-------------
â”œâ”€â”€ DivNode
â”‚   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
â”‚   inner_content: `{maketoc Title=&quot;&quot;}`
â”‚   attrs_dict:
â”‚   â”‚   raw_content: (class=&quot;lefth4&quot;)
â”‚   â”‚   class: lefth4
â”‚   children:
â”‚   â”œâ”€â”€ MakeTocNode
â”‚   â”‚   full_match: `{maketoc Title=&quot;&quot;}`
â”‚   â”‚   inner_content: ``
â”‚   â”‚   attrs_dict:
â”‚   â”‚   â”‚   raw_content:  Title=&quot;&quot;
â”‚   â”‚   â”‚   Title: â”œâ”€â”€ HorizontalRuleNode
â”‚   full_match: `\n---\n`
â”‚   inner_content: `---`â”œâ”€â”€ HeadingNode
â”‚   full_match: `!!!!A Randomized Controlled Trial of Vitamin D Supplementation in Iranian Patients With Schizophrenia: Effects on Serum Levels of Glycogen Synthase kinase-3Î² and Symptom Severity`
â”‚   inner_content: `A Randomized Controlled Trial of Vitamin D Supplementation in Iranian Patients With Schizophrenia: Effects on Serum Levels of Glycogen Synthase kinase-3Î² and Symptom Severity`
â”‚   level: `4`
â”‚   children:
â”‚   â”œâ”€â”€ TextNode
â”‚   â”‚   full_match: `A Randomized Controlled Trial of Vitamin D Supplementation in Iranian Patients With Schizophrenia: Effects on Serum Levels of Glycogen Synthase kinase-3Î² and Symptom Severity`
â”‚   â”‚   inner_content: `A Randomized Controlled Trial of Vitamin D Supplementation in Iranian Patients With Schizophrenia: Effects on Serum Levels of Glycogen Synthase kinase-3Î² and Symptom Severity`â”œâ”€â”€ TextNode
â”‚   full_match: `\nInt J Psychiatry Med. 2023 Aug 6; `
â”‚   inner_content: `\nInt J Psychiatry Med. 2023 Aug 6; `â”œâ”€â”€ DoiLinkNode
â”‚   full_match: `doi: 10.1177/00912174231193303`
â”‚   inner_content: `10.1177/00912174231193303`â”œâ”€â”€ TextNode
â”‚   full_match: ` `
â”‚   inner_content: ` `â”œâ”€â”€ HorizontalSpaceNode
â”‚   full_match: `~hs~`
â”‚   inner_content: ``
â”‚   repetitions: `1`â”œâ”€â”€ TextNode
â”‚   full_match: ` behind a $41 paywall\nParinaz Kalejahi 1, Sorayya Kheirouri 1, Seyed Gholamreza Noorazar 2\n\nBackground: Growing evidence has shown that hypovitaminosis D is a risk factor for developing schizophrenia and comorbid conditions. Therefore, this study aimed to examine the effect of vitamin D supplementation on serum levels of vitamin D, metabolic factors related to insulin resistance (IR) and the severity of the disorder in patients with schizophrenia.\n\nMethods: Forty-eight chronic male patients with schizophrenia with vitamin D deficiency (â‰¤20 ng/mL= (â‰¤50 nmol/l) were selected and randomly assigned to vitamin D treatment and placebo groups. Subjects were supplemented for 8 weeks with vitamin D (2000 IU/day) and placebo, respectively.\n\nResults: Within-group comparison revealed that the vitamin D group had a significant reduction in waist circumference, Positive and Negative Syndrome Scale - total score (PANSS-TS) and, glycogen synthase kinase 3 beta (GSK-3Î²) levels (P = .022, p = &lt;.001 and P = .013 respectively). On the other hand, the placebo group showed a significant increase in the level of fasting serum insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) (P = .003 and P = .003). The between-group comparison showed a significant difference in terms of PANSS-TS, GSK-3Î², Fasting serum insulin (FSI) and HOMA-IR (P = .022, P = .048, P = .013 and P = .014 respectively).\n\nConclusions: Among vitamin D deficient patients with schizophrenia, vitamin D supplementation may affect GSK-3 Î², an important biomarker in schizophrenia and insulin resistance. In addition, vitamin D supplementation in such patients may reduce symptom severity.`
â”‚   inner_content: ` behind a $41 paywall\nParinaz Kalejahi 1, Sorayya Kheirouri 1, Seyed Gholamreza Noorazar 2\n\nBackground: Growing evidence has shown that hypovitaminosis D is a risk factor for developing schizophrenia and comorbid conditions. Therefore, this study aimed to examine the effect of vitamin D supplementation on serum levels of vitamin D, metabolic factors related to insulin resistance (IR) and the severity of the disorder in patients with schizophrenia.\n\nMethods: Forty-eight chronic male patients with schizophrenia with vitamin D deficiency (â‰¤20 ng/mL= (â‰¤50 nmol/l) were selected and randomly assigned to vitamin D treatment and placebo groups. Subjects were supplemented for 8 weeks with vitamin D (2000 IU/day) and placebo, respectively.\n\nResults: Within-group comparison revealed that the vitamin D group had a significant reduction in waist circumference, Positive and Negative Syndrome Scale - total score (PANSS-TS) and, glycogen synthase kinase 3 beta (GSK-3Î²) levels (P = .022, p = &lt;.001 and P = .013 respectively). On the other hand, the placebo group showed a significant increase in the level of fasting serum insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) (P = .003 and P = .003). The between-group comparison showed a significant difference in terms of PANSS-TS, GSK-3Î², Fasting serum insulin (FSI) and HOMA-IR (P = .022, P = .048, P = .013 and P = .014 respectively).\n\nConclusions: Among vitamin D deficient patients with schizophrenia, vitamin D supplementation may affect GSK-3 Î², an important biomarker in schizophrenia and insulin resistance. In addition, vitamin D supplementation in such patients may reduce symptom severity.`â”œâ”€â”€ HorizontalRuleNode
â”‚   full_match: `\n---\n`
â”‚   inner_content: `---`â”œâ”€â”€ HeadingNode
â”‚   full_match: `!!!!VitaminDWiki - ((Overview Schizophrenia and Vitamin D)) contains `
â”‚   inner_content: `VitaminDWiki - ((Overview Schizophrenia and Vitamin D)) contains`
â”‚   level: `4`
â”‚   children:
â”‚   â”œâ”€â”€ TextNode
â”‚   â”‚   full_match: `VitaminDWiki - `
â”‚   â”‚   inner_content: `VitaminDWiki - `
â”‚   â”œâ”€â”€ LocalLinkNode
â”‚   â”‚   full_match: `((Overview Schizophrenia and Vitamin D))`
â”‚   â”‚   inner_content: `Overview Schizophrenia and Vitamin D`
â”‚   â”‚   page: `Overview Schizophrenia and Vitamin D`
â”‚   â”‚   children:
â”‚   â”‚   â”œâ”€â”€ TextNode
â”‚   â”‚   â”‚   full_match: `Overview Schizophrenia and Vitamin D`
â”‚   â”‚   â”‚   inner_content: `Overview Schizophrenia and Vitamin D`
â”‚   â”œâ”€â”€ TextNode
â”‚   â”‚   full_match: ` contains`
â”‚   â”‚   inner_content: ` contains`â”œâ”€â”€ TextNode
â”‚   full_match: `\n`
â”‚   inner_content: `\n`â”œâ”€â”€ IncludeNode
â”‚   full_match: `{include page=&quot;Overview Schizophrenia and Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
â”‚   inner_content: ``
â”‚   attrs_dict:
â”‚   â”‚   raw_content:  page=&quot;Overview Schizophrenia and Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
â”‚   â”‚   page: Overview Schizophrenia and Vitamin D
â”‚   â”‚   start: ~tc~ start ~/tc~
â”‚   â”‚   stop: ~tc~ end ~/tc~
â”‚   children:
â”‚   â”œâ”€â”€ TextNode
â”‚   â”‚   full_match: ``
â”‚   â”‚   inner_content: ``â”œâ”€â”€ HorizontalRuleNode
â”‚   full_match: `\n---\n`
â”‚   inner_content: `---`â”œâ”€â”€ HeadingNode
â”‚   full_match: `!!!!VitaminDWiki - ((Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021))`
â”‚   inner_content: `VitaminDWiki - ((Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021))`
â”‚   level: `4`
â”‚   children:
â”‚   â”œâ”€â”€ TextNode
â”‚   â”‚   full_match: `VitaminDWiki - `
â”‚   â”‚   inner_content: `VitaminDWiki - `
â”‚   â”œâ”€â”€ LocalLinkNode
â”‚   â”‚   full_match: `((Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021))`
â”‚   â”‚   inner_content: `Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021`
â”‚   â”‚   page: `Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021`
â”‚   â”‚   children:
â”‚   â”‚   â”œâ”€â”€ TextNode
â”‚   â”‚   â”‚   full_match: `Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021`
â”‚   â”‚   â”‚   inner_content: `Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021`â”œâ”€â”€ TextNode
â”‚   full_match: `\n`
â”‚   inner_content: `\n`â”œâ”€â”€ BoldNode
â”‚   full_match: `__The goal: everyone &gt; 30 ng__`
â”‚   inner_content: `The goal: everyone &gt; 30 ng`
â”‚   children:
â”‚   â”œâ”€â”€ TextNode
â”‚   â”‚   full_match: `The goal: everyone &gt; 30 ng`
â”‚   â”‚   inner_content: `The goal: everyone &gt; 30 ng`â”œâ”€â”€ TextNode
â”‚   full_match: `\n`
â”‚   inner_content: `\n`â”œâ”€â”€ BoldNode
â”‚   full_match: `__Those with the lowest vitamin D levels were given 50,000 IU weekly for 8 weeks__`
â”‚   inner_content: `Those with the lowest vitamin D levels were given 50,000 IU weekly for 8 weeks`
â”‚   children:
â”‚   â”œâ”€â”€ TextNode
â”‚   â”‚   full_match: `Those with the lowest vitamin D levels were given 50,000 IU weekly for 8 weeks`
â”‚   â”‚   inner_content: `Those with the lowest vitamin D levels were given 50,000 IU weekly for 8 weeks`â”œâ”€â”€ TextNode
â”‚   full_match: `\n`
â”‚   inner_content: `\n`

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!A Randomized Controlled Trial of Vitamin D Supplementation in Iranian Patients With Schizophrenia: Effects on Serum Levels of Glycogen Synthase kinase-3Î² and Symptom Severity
Int J Psychiatry Med. 2023 Aug 6; doi: 10.1177/00912174231193303 ~hs~ behind a $41 paywall
Parinaz Kalejahi 1, Sorayya Kheirouri 1, Seyed Gholamreza Noorazar 2

Background: Growing evidence has shown that hypovitaminosis D is a risk factor for developing schizophrenia and comorbid conditions. Therefore, this study aimed to examine the effect of vitamin D supplementation on serum levels of vitamin D, metabolic factors related to insulin resistance (IR) and the severity of the disorder in patients with schizophrenia.

Methods: Forty-eight chronic male patients with schizophrenia with vitamin D deficiency (â‰¤20 ng/mL= (â‰¤50 nmol/l) were selected and randomly assigned to vitamin D treatment and placebo groups. Subjects were supplemented for 8 weeks with vitamin D (2000 IU/day) and placebo, respectively.

Results: Within-group comparison revealed that the vitamin D group had a significant reduction in waist circumference, Positive and Negative Syndrome Scale - total score (PANSS-TS) and, glycogen synthase kinase 3 beta (GSK-3Î²) levels (P = .022, p = &lt;.001 and P = .013 respectively). On the other hand, the placebo group showed a significant increase in the level of fasting serum insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) (P = .003 and P = .003). The between-group comparison showed a significant difference in terms of PANSS-TS, GSK-3Î², Fasting serum insulin (FSI) and HOMA-IR (P = .022, P = .048, P = .013 and P = .014 respectively).

Conclusions: Among vitamin D deficient patients with schizophrenia, vitamin D supplementation may affect GSK-3 Î², an important biomarker in schizophrenia and insulin resistance. In addition, vitamin D supplementation in such patients may reduce symptom severity.
---
!!!!VitaminDWiki - ((Overview Schizophrenia and Vitamin D)) contains 
{include page=&quot;Overview Schizophrenia and Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}
---
!!!!VitaminDWiki - ((Every schizophrenia measure was improved when vitamin D levels were normalized â€“ June 2021))
__The goal: everyone &gt; 30 ng__
__Those with the lowest vitamin D levels were given 50,000 IU weekly for 8 weeks__

</code>
</pre>

    </article>

        </div>
    </div>

    <script src="/js/lightspa.js?v=1742566339"></script>
    <script>
        
        const spa = new LightSPA({
            mainContentSelector: '[role="main"]',
            navigationSelector: '[data-spa-nav]'
        });

        
        const search = new Search({
            documentsUrl: '\/js\/search_documents.json?v=1742566339',
            indexUrl: '\/js\/search_index.json?v=1742566339'
        });
    </script>
</body>
</html>